Sort
34,240 grants matching “atherosclerosis”
Polymorphic ApoE at the crossroad of lipid metabolism and inflammation in atherosclerosis
$614,941David Y Hui · University Of Cincinnati · R01 · FY2022 · HL
Identifying Epidemiological Risk Factors for Abdominal Aortic Aneurysm
$614,928Weihong Tang · University Of Minnesota · R01 · FY2012 · HL
Neighborhoods and Cardiovascular Risk in a Multiethnic Cohort
$614,892Ana V Diez Roux · University Of Michigan At Ann Arbor · R01 · FY2012 · HL
CVD GENETIC PREDISPOSITIONS AND GENOMIC SIGNATURES
$614,818Winston C Patterson · Univ Of North Carolina Chapel Hill · P50 · FY2010 · HL
Genetic Markers of CHD in Type 2 Diabetes
$614,815Frank B Hu · Harvard School Of Public Health · R01 · FY2006 · HL
Heart Disease in Rheumatoid Arthritis
$614,793Sherine E Gabriel · Mayo Clinic Rochester · R01 · FY2008 · AR
Synthetic Counter-ligands for Inhibition of Atherosclerosis
$614,782Prabhas V Moghe · Rutgers, The State Univ Of N.J. · R01 · FY2011 · HL
Echogenic Targeted Liposomes:Transfection/Drug Delivery
$614,729Northwestern University · R01 · FY2004 · HL
Antibacterial Host Defense
$614,727Robert Munford · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
HIGH FREQUENCY NONLINEAR ACOUSTIC INTRAVASCULAR IMAGING
$614,650Cleveland Clinic Foundation · R01 · FY2003 · HL
Effect of cell-based therapies on functional, hemodynamic, and histologic outcomes in a porcine model of peripheral arterial disease
$614,558Iraklis Ilias Pipinos · University Of Nebraska Medical Center · R01 · FY2020 · AG
Nanoparticles for Molecular MRI of Atherosclerosis
$614,449Mount Sinai School Of Medicine Of Nyu · R01 · FY2004 · HL
Neighborhood Environments and Cardiometabolic Disorders in Hispanic/Latinos
$614,447Matthew A Allison · University Of California, San Diego · R01 · FY2016 · DK
Pharmacogenomic studies in VISP: results & implications for clinical trial design
$614,434Michele M Sale · University Of Virginia · U01 · FY2010 · HG
Licensing LncRNAs in Atherosclerosis
$614,422Tamer Sallam · University Of California Los Angeles · R01 · FY2024 · HL
Strategies and Functional Outcomes of Enhancing in Vivo Production of Soluble Rage Isoforms
$614,386Jacob M Haus · University Of Michigan At Ann Arbor · R01 · FY2019 · DK
Role of Peripheral Immune Cells in Cognitive Aging: The Framingham Offspring Study
$614,222Joanne M Murabito · Boston University Medical Campus · R01 · FY2023 · AG
ClinSeq(c) - Molecular and Genetic Aspects
$614,171Leslie Biesecker · National Human Genome Research Institute · ZIA · FY2013 · HG
The characterization of Cela2a, a novel disease gene for metabolic syndrome in health and diseases
$614,168Arya Mani · Yale University · R01 · FY2025 · DK
Impact of Clonal Hematopoiesis on the Progression of Kidney Disease
$614,096Cassianne Robinson-Cohen · Vanderbilt University Medical Center · R01 · FY2024 · DK
IRAS FAMILY STUDY--GENETICS OF INSULIN RESISTANCE
$613,999Wake Forest University Health Sciences · R01 · FY2002 · HL
Strategies and Functional Outcomes of Enhancing in Vivo Production of Soluble Rage Isoforms
$613,936Jacob M Haus · University Of Michigan At Ann Arbor · R01 · FY2020 · DK
Determinants of Myogenic, Fibroblastic, and Neuronal Membrane Phenomena
$613,933Alan F Horwitz · University Of Virginia · R01 · FY2011 · GM
Genetics of Coronary Artery Disease in Type 2 Diabetes
$613,928Alessandro Doria · Joslin Diabetes Center · R01 · FY2009 · HL
Determinants of Myogenic, Fibroblastic, and Neuronal Membrane Phenomena
$613,923Alan F Horwitz · University Of Virginia · R01 · FY2012 · GM